+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Global Pediatric Vaccine Market (2023-2028) by Type, Technology, Applications, and Geography, Competitive Analysis, Impact of Covid-19, Impact of Economic Slowdown & Impending Recession with Ansoff Analysis

  • PDF Icon


  • 174 Pages
  • January 2023
  • Region: Global
  • Infogence Global Research
  • ID: 5749029

According to Unicef, the global vaccination continues to decline in 2021 with 25 million children missing out on lifesaving vaccines

The Global Pediatric Vaccine Market is estimated to be USD 59.98 Bn in 2023 and is expected to reach USD 98.55 Bn by 2028, growing at a CAGR of 10.44%.

Market Dynamics

Market dynamics are forces that impact the prices and behaviors of the stakeholders. These forces create pricing signals which result from the changes in the supply and demand curves for a given product or service. Forces of Market Dynamics may be related to macro-economic and micro-economic factors. There are dynamic market forces other than price, demand, and supply. Human emotions can also drive decisions, influence the market, and create price signals.

As the market dynamics impact the supply and demand curves, decision-makers aim to determine the best way to use various financial tools to stem various strategies for speeding the growth and reducing the risks.

Market Segmentations

The Global Pediatric Vaccine Market is segmented based on Type, Technology, Applications, and Geography.
  • By Type, the market is classified into Multivalent and Monovalent.
  • By Technology, the market is classified into Conjugate, Live Attenuated, Inactivated, Subunit, and Toxoid.
  • By Applications, the market is classified into Infectious Disease, Cancer, and Allergy.
  • By Geography, the market is classified into Americas, Europe, Middle-East & Africa, and Asia-Pacific.

Company Profiles

The report provides a detailed analysis of the competitors in the market. It covers the financial performance analysis for the publicly listed companies in the market. The report also offers detailed information on the companies' recent development and competitive scenario. Some of the companies covered in this report are Abbott Laboratories, GSK PLC, Merck & Co., Inc., Pfizer, Inc., Sanofi SA, Serum Institute of India Pvt. Ltd., etc.

Countries Studied

  • America (Argentina, Brazil, Canada, Chile, Colombia, Mexico, Peru, United States, Rest of Americas)
  • Europe (Austria, Belgium, Denmark, Finland, France, Germany, Italy, Netherlands, Norway, Poland, Russia, Spain, Sweden, Switzerland, United Kingdom, Rest of Europe)
  • Middle-East and Africa (Egypt, Israel, Qatar, Saudi Arabia, South Africa, United Arab Emirates, Rest of MEA)
  • Asia-Pacific (Australia, Bangladesh, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Sri Lanka, Thailand, Taiwan, Rest of Asia-Pacific)

Competitive Quadrant

The report includes a Competitive Quadrant, a proprietary tool to analyze and evaluate the position of companies based on their Industry Position score and Market Performance score. The tool uses various factors for categorizing the players into four categories. Some of these factors considered for analysis are financial performance over the last 3 years, growth strategies, innovation score, new product launches, investments, growth in market share, etc.

Ansoff Analysis

The report presents a detailed Ansoff matrix analysis for the Global Pediatric Vaccine Market. Ansoff Matrix, also known as Product/Market Expansion Grid, is a strategic tool used to design strategies for the growth of the company. The matrix can be used to evaluate approaches in four strategies viz. Market Development, Market Penetration, Product Development and Diversification. The matrix is also used for risk analysis to understand the risk involved with each approach.

The analyst analyses the Global Pediatric Vaccine Market using the Ansoff Matrix to provide the best approaches a company can take to improve its market position.

Based on the SWOT analysis conducted on the industry and industry players, the analyst has devised suitable strategies for market growth.

Why buy this report?

  • The report offers a comprehensive evaluation of the Global Pediatric Vaccine Market. The report includes in-depth qualitative analysis, verifiable data from authentic sources, and projections about market size. The projections are calculated using proven research methodologies.
  • The report has been compiled through extensive primary and secondary research. The primary research is done through interviews, surveys, and observation of renowned personnel in the industry.
  • The report includes an in-depth market analysis using Porter's 5 forces model, PESTLE Analysis, and the Ansoff Matrix. In addition, the impact of COVID-19 and the impact of economic slowdown & impending recession on the market are also featured in the report.
  • The report also includes the regulatory scenario in the industry, which will help you make a well-informed decision. The report discusses major regulatory bodies and major rules and regulations imposed on this sector across various geographies.
  • The report also contains the competitive analysis using Positioning Quadrants, the analyst's competitive positioning tool.

Report Highlights:

  • A complete analysis of the market, including parent industry
  • Important market dynamics and trends
  • Market segmentation
  • Historical, current, and projected size of the market based on value and volume
  • Market shares and strategies of key players
  • Recommendations to companies for strengthening their foothold in the market
Frequently Asked Questions about the Global Pediatric Vaccine Market

What is the estimated value of the Global Pediatric Vaccine Market?

The Global Pediatric Vaccine Market was estimated to be valued at $59.98 Billion in 2023.

What is the growth rate of the Global Pediatric Vaccine Market?

The growth rate of the Global Pediatric Vaccine Market is 10.4%, with an estimated value of $98.55 Billion by 2028.

What is the forecasted size of the Global Pediatric Vaccine Market?

The Global Pediatric Vaccine Market is estimated to be worth $98.55 Billion by 2028.

Who are the key companies in the Global Pediatric Vaccine Market?

Key companies in the Global Pediatric Vaccine Market include Abbott Laboratories, Astellas Pharma, Inc., AstraZeneca PLC, Bristol, Myers Squibb Co., Cadila Healthcare Ltd., Daiichi Sankyo Co. Ltd., Eli Lilly and Co., GSK PLC and Grifols SA.

Table of Contents

1 Report Description
1.1 Study Objectives
1.2 Market Definition
1.3 Currency
1.4 Years Considered
1.5 Language
1.6 Key Stakeholders

2 Research Methodology
2.1 Research Process
2.2 Data Collection and Validation
2.2.1 Secondary Research
2.2.2 Primary Research
2.2.3 Models
2.3 Market Size Estimation
2.3.1 Bottom-Up Approach
2.3.2 Top-Down Approach
2.4 Assumptions of the Study
2.5 Limitations of the Study

3 Executive Summary
3.1 Introduction
3.2 Market Size, Segmentations, and Outlook

4 Market Dynamics
4.1 Drivers
4.1.1 Rising Burden of Chronic Diseases
4.1.2 Technological Advancements in Vaccines
4.1.3 Favorable Government Support in Promoting Vaccination
4.2 Restraints
4.2.1 High Cost of Immunization
4.2.2 Stringent Government Regulations
4.3 Opportunities
4.3.1 Development of Efficacious & Safe Vaccination to Prevent Dangerous Diseases
4.3.2 Rising Number of Government and Private Collaborations and Expansions
4.4 Challenges
4.4.1 Refusal of Immunization due to Low Awareness in Rural Areas

5 Market Analysis
5.1 Regulatory Scenario
5.2 Porter's Five Forces Analysis
5.3 PESTLE Analysis
5.4 SWOT Analysis
5.5 Impact of COVID-19
5.6 Impact of Economic Slowdown & Impending Recession
5.7 Ansoff Matrix Analysis

6 Global Pediatric Vaccine Market, By Type
6.1 Introduction
6.2 Multivalent
6.3 Monovalent

7 Global Pediatric Vaccine Market, By Technology
7.1 Introduction
7.2 Conjugate
7.3 Live Attenuated
7.4 Inactivated
7.5 Subunit
7.6 Toxoid

8 Global Pediatric Vaccine Market, By Applications
8.1 Introduction
8.2 Infectious Disease
8.3 Cancer
8.4 Allergy

9 Americas' Pediatric Vaccine Market
9.1 Introduction
9.2 Argentina
9.3 Brazil
9.4 Canada
9.5 Chile
9.6 Colombia
9.7 Mexico
9.8 Peru
9.9 United States
9.10 Rest of Americas

10 Europe's Pediatric Vaccine Market
10.1 Introduction
10.2 Austria
10.3 Belgium
10.4 Denmark
10.5 Finland
10.6 France
10.7 Germany
10.8 Italy
10.9 Netherlands
10.10 Norway
10.11 Poland
10.12 Russia
10.13 Spain
10.14 Sweden
10.15 Switzerland
10.16 United Kingdom
10.17 Rest of Europe

11 Middle East and Africa's Pediatric Vaccine Market
11.1 Introduction
11.2 Egypt
11.3 Israel
11.4 Qatar
11.5 Saudi Arabia
11.6 South Africa
11.7 United Arab Emirates
11.8 Rest of MEA

12 APAC's Pediatric Vaccine Market
12.1 Introduction
12.2 Australia
12.3 Bangladesh
12.4 China
12.5 India
12.6 Indonesia
12.7 Japan
12.8 Malaysia
12.9 Philippines
12.10 Singapore
12.11 South Korea
12.12 Sri Lanka
12.13 Thailand
12.14 Taiwan
12.15 Rest of Asia-Pacific

13 Competitive Landscape
13.1 Competitive Quadrant
13.2 Market Share Analysis
13.3 Strategic Initiatives
13.3.1 M&A and Investments
13.3.2 Partnerships and Collaborations
13.3.3 Product Developments and Improvements

14 Company Profiles
14.1 Abbott Laboratories
14.2 Astellas Pharma, Inc.
14.3 AstraZeneca PLC
14.4 Bristol-Myers Squibb Co.
14.5 Cadila Healthcare Ltd.
14.6 Daiichi Sankyo Co. Ltd.
14.7 Eli Lilly and Co.
14.8 GSK PLC
14.9 Grifols SA
14.10 Indian Immunologicals Ltd.
14.11 Johnson & Johnson
14.12 Merck & Co., Inc.
14.13 Mitsubishi Tanabe Pharma Corp.
14.14 Novo Nordisk AS
14.15 Panacea Biotec
14.16 Pfizer, Inc.
14.17 Sanofi SA
14.18 Seqirus UK Ltd. (CSL Limited)
14.19 Serum Institute of India Pvt. Ltd.
14.20 Sinovac Biotech Ltd.

15 Appendix
15.1 Questionnaire

Companies Mentioned

  • Abbott Laboratories
  • Astellas Pharma, Inc.
  • AstraZeneca PLC
  • Bristol-Myers Squibb Co.
  • Cadila Healthcare Ltd.
  • Daiichi Sankyo Co. Ltd.
  • Eli Lilly and Co.
  • Grifols SA
  • Indian Immunologicals Ltd.
  • Johnson & Johnson
  • Merck & Co., Inc.
  • Mitsubishi Tanabe Pharma Corp.
  • Novo Nordisk AS
  • Panacea Biotec
  • Pfizer, Inc.
  • Sanofi SA
  • Seqirus UK Ltd. (CSL Limited)
  • Serum Institute of India Pvt. Ltd.
  • Sinovac Biotech Ltd.